Physician profile
Amanda Hall
NPI 1558723106
$962.97
in general payments reported to CMS, 2019-2025
11 companies · $75.21 in 2025
The $75.21 reported for 2025 was less than what a typical Pediatrics (Nurse Practitioner) provider received nationally (typical 2025 total: $93.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $14.57 · 2022: $519 · 2023: $173 · 2024: $180 · 2025: $75.21.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $429.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $428.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $498.53 | 2022-2023 | Proclaim |
| Corium, LLC | $177.22 | 2022-2025 | Azstarys |
| Verrica Pharmaceuticals INC. | $124.98 | 2024 | Ycanth |
| Glaxosmithkline, LLC. | $34.22 | 2021-2023 | Pediarix |
| Pharming Healthcare, INC. | $26.93 | 2023 | Ruconest |
| Biogen, INC. | $22.51 | 2025 | Vumerity, Tysabri |
| Takeda Pharmaceuticals U.S.A., INC. | $19.75 | 2022 | |
| Idorsia Pharmaceuticals US INC | $16.62 | 2022 | |
| Sanofi Pasteur INC. | $14.62 | 2025 | |
| Aytu Biopharma, INC. | $13.80 | 2024 | Karbinal |
| Merck Sharp & Dohme LLC | $13.79 | 2025 | Gardasil 9, Enflonsia, Vaxneuvance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.